Urinary Bag Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Large Bags, Leg Bags), By Usage (Reusable, Disposable), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml), By End Use (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.55 Billion
CAGR (2026-2031)	4.13%
Fastest Growing Segment	Leg Bags
Largest Market	North America
Market Size (2031)	USD 3.25 Billion

Market Overview

The Global Urinary Bag Market will grow from USD 2.55 Billion in 2025 to USD 3.25 Billion by 2031 at a 4.13% CAGR. Urinary bags are sterile medical devices designed to collect and store urine from patients unable to void naturally due to incontinence or surgical recovery. The primary drivers fueling market growth include a rapidly aging global demographic and the rising prevalence of chronic urological conditions which necessitate effective drainage solutions. According to the American Urological Association, in 2024, the prevalence of benign prostatic hyperplasia among men aged 65 and older reached approximately 29% to 35%. This high incidence rate underscores the sustained demand for urine collection products while increasing surgical volumes further bolster the sector independent of passing design trends.

However, the market faces a substantial obstacle regarding the high risk of infections associated with urinary catheters. Healthcare facilities are increasingly implementing rigorous protocols to minimize catheterization duration to ensure patient safety and reduce hospital liabilities. This clinical shift toward reducing invasive drainage methods limits the adoption rate of urinary bags for long term management and presents a notable constraint on overall market volume expansion.

Key Market Drivers

Rapid Expansion of the Global Geriatric Population acts as a primary catalyst for market adoption, as aging significantly correlates with the loss of bladder control and mobility-related impairments. As life expectancy increases, the number of individuals requiring long-term incontinence management solutions, such as urinary bags, rises proportionately. According to the Population Reference Bureau, September 2024, in the '2024 World Population Data Sheet', the global population aged 65 and older has surpassed 800 million, representing approximately 10% of the total population. This demographic shift creates a stable, expanding patient pool that necessitates reliable urine collection devices independent of economic cycles, compelling manufacturers to scale production for an older demographic prone to chronic urological deficits.

Growing Preference for Home-Based Healthcare Services further accelerates market momentum by shifting patient management from clinical settings to domestic environments. This trend drives the demand for discreet, user-friendly urinary bags that facilitate self-care and improve the quality of life for chronic patients. According to Coloplast, November 2024, in the 'Annual Report 2023/24', the company's Continence Care business area delivered an organic growth rate of 8%, underscoring the robust demand for chronic care products outside the hospital. Additionally, the prevalence of conditions requiring surgical intervention supports this trajectory; according to the American Cancer Society, in 2024, an estimated 83,190 new cases of urinary bladder cancer were diagnosed in the United States, sustaining the need for post-operative drainage systems in both acute and home care settings.

Download Free Sample Report

Key Market Challenges

The primary constraint impeding the expansion of the Global Urinary Bag Market is the elevated risk of catheter-associated urinary tract infections (CAUTIs). This clinical danger has forced healthcare providers to fundamentally alter their approach to patient care by prioritizing the early removal of indwelling catheters to minimize hospital liabilities. Because urinary bags are consumable products directly tied to the duration of catheterization, strict hospital protocols that limit usage time directly reduce the recurring sales volume for manufacturers. The market is consequently restricted as medical facilities transition patients to alternative, non-invasive incontinence management methods to avoid the severe financial and reputational costs linked to hospital-acquired conditions.

The impact of these exclusionary measures is evident in recent industry performance metrics which highlight the correlation between safety protocols and reduced device utility. According to The Leapfrog Group, in 2024, the prevalence of catheter-associated urinary tract infections decreased by 36% across monitored facilities. This significant statistical drop reflects a successful industry-wide effort to minimize reliance on invasive urinary devices. While beneficial for patient safety, this trend confirms a substantial reduction in total catheter days, thereby acting as a powerful brake on the consumable volume growth of the urinary bag sector.

Key Market Trends

The Adoption of Biodegradable and Eco-Friendly Manufacturing Materials is reshaping the global urinary bag market as manufacturers actively align with environmental sustainability goals to reduce medical plastic waste. Leading medical device companies are increasingly transitioning from traditional polyvinyl chloride (PVC) and single-use plastics toward renewable, bio-based polymers and recyclable alternatives that maintain clinical sterility while minimizing ecological impact. This shift is driven by regulatory pressures and healthcare procurement policies prioritizing low-carbon supply chains, compelling the industry to innovate its production lifecycles. According to Coloplast, November 2025, in the 'Annual Report 2024/25', the company successfully increased its production waste recycling rate to 83%, surpassing its ambition of 75% and highlighting the rapid industrial pivot toward circular manufacturing practices in the continence care sector.

Simultaneously, there is an Accelerated Shift Toward Single-Use Disposable Systems for Infection Prevention, focused on integrating advanced antimicrobial technologies directly into drainage products. To combat catheter-associated urinary tract infections (CAUTIs), the market is moving beyond standard drainage bags to sophisticated, closed-system solutions featuring anti-infective coatings and refined valve mechanisms that prevent bacterial migration. This trend is evidenced by the commercial expansion of infection-preventing technologies through strategic partnerships. According to Bactiguard Holding AB, February 2025, in the 'Year-end report 2024', license revenues from its partnership with Becton, Dickinson and Company (BD) for infection prevention technologies increased by 33.9% to SEK 124.7 million, underscoring the growing market adoption of coated urinary devices designed to enhance patient safety.

Segmental Insights

The leg bags segment is currently positioning itself as the fastest-growing category within the global urinary bag market due to the increasing demand for patient mobility and independent living. Unlike large capacity bags used primarily for bedridden patients, leg bags allow individuals to maintain an active lifestyle while managing urinary incontinence discreetly. This expansion is further driven by the global shift towards home-based healthcare, supported by reimbursement frameworks from organizations such as the Centers for Medicare and Medicaid Services that facilitate access to essential ambulatory care supplies.

Regional Insights

North America maintains a leading position in the global urinary bag market, driven by established healthcare infrastructure and a rising prevalence of urological disorders. The region benefits from supportive reimbursement frameworks managed by the Centers for Medicare & Medicaid Services, which improve affordability and patient access to essential medical supplies. Furthermore, the U.S. Food and Drug Administration enforces rigorous safety standards that sustain confidence in medical devices. These factors, combined with increasing awareness regarding urinary incontinence management, ensure North America remains the primary market for urological products.

Recent Developments

• In December 2025, Teleflex Incorporated entered into a definitive agreement to divest its Acute Care and Interventional Urology businesses to Intersurgical for approximately $530 million in cash. This strategic transaction was part of a broader restructuring plan by Teleflex to optimize its portfolio and focus on other high-growth areas. For Intersurgical, the acquisition was intended to expand its product offerings in the urology sector, integrating established brands and technical expertise into its existing medical device operations. The deal highlighted a significant consolidation effort within the global market for urinary and critical care devices.
• In July 2024, Convatec Group Plc announced the launch of the GentleCath Air for Women with FeelClean Technology in the United Kingdom and Italy, following an earlier debut in France. This compact intermittent catheter was engineered to integrate hydrophilic properties directly into the catheter material, a design intended to minimize mess and reduce sticking during use. The product aims to protect the urethral mucosa and lower the risk of urinary tract infections, a common concern for long-term catheter users. This introduction underscored the company's focus on innovation in the continence care market to enhance user comfort and discretion.
• In May 2024, Coloplast A/S expanded its intermittent catheter portfolio with the initiation of the launch of Luja for women. This new product features the company's proprietary Micro-hole Zone Technology, which was previously introduced in the male version of the catheter. The design aims to reduce the risk of urinary tract infections by ensuring completely emptied bladders through multiple micro-holes that facilitate urine flow. The launch began in key markets and represented a strategic move to strengthen the company's position in the continence care segment by offering advanced solutions tailored specifically to female anatomy and user needs.
• In April 2024, Ingenion Medical Ltd. achieved a significant regulatory milestone by receiving the CE mark for its Cymactive 2.0R urinary catheter. This certification allowed the company to commence sales and marketing of the device across Europe for the treatment of men with chronic, non-neurogenic urinary retention. The Cymactive 2.0R was designed to mimic natural urination and serves as an alternative to traditional Foley and intermittent catheters. The device features a specialized anchor system and a valve that enables users to control bladder emptying with an external magnet, aiming to improve patient quality of life and reduce catheter-associated infections.

Key Market Players

• ConvaTec, Inc.
• Cardinal Health
• Teleflex, Inc.
• Coloplast
• McKesson Medical Surgical, Inc.
• Amsino International, Inc.
• Flexicare Medical Ltd.
• Medline Industries, Inc.
• Manfred Sauer GmbH
• Romsons Group

By Product	By Usage	By Capacity	By End Use	By Region
Large Bags Leg Bags	Reusable Disposable	0-500 ml 500-1000 ml 1000-2000 ml	Hospitals Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Urinary Bag Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Urinary Bag Market, By Product:

• Large Bags
• Leg Bags

• Urinary Bag Market, By Usage:

• Reusable
• Disposable

• Urinary Bag Market, By Capacity:

• 0-500 ml
• 500-1000 ml
• 1000-2000 ml

• Urinary Bag Market, By End Use:

• Hospitals
• Clinics
• Others

• Urinary Bag Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE